Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jiatao Liao"'
Autor:
Chang Liu, Jiatao Liao, Xianghua Wu, Xinmin Zhao, Si Sun, Huijie Wang, Zhihuang Hu, Yao Zhang, Hui Yu, Jialei Wang
Publikováno v:
Thoracic Cancer, Vol 13, Iss 10, Pp 1463-1470 (2022)
Abstract Background The aim of this prospective, pilot, single‐arm phase II trial was to evaluate the safety and efficacy of anlotinib combined with etoposide and platinum‐based regimens in the first‐line treatment of extensive‐stage small ce
Externí odkaz:
https://doaj.org/article/2637b6ff2dc5424eadb060b0d65faaff
Autor:
Chang Liu, Jinying Chen, Jiatao Liao, Yuchen Li, Hui Yu, Xinmin Zhao, Si Sun, Zhihuang Hu, Yao Zhang, Zhengfei Zhu, Min Fan, Shenglin Huang, Jialei Wang
Publikováno v:
Cancers, Vol 14, Iss 22, p 5493 (2022)
(1) Introduction: The aim of this study was to identify the plasma extracellular vesicle (EV)-specific transcriptional profile in small-cell lung cancer (SCLC) and to explore the application value of plasma EV long RNA (exLR) in SCLC treatment predic
Externí odkaz:
https://doaj.org/article/5512042f488448fda5448671681a39a2
Autor:
Jiatao Liao, Chang Liu, Qianqian Long, Xianghua Wu, Huijie Wang, Hui Yu, Si Sun, Yao Zhang, Ying Lin, Xinmin Zhao, Jialei Wang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundThe addition of bevacizumab or pembrolizumab to pemetrexed-platinum chemotherapy has produced significant clinical benefits to patients with untreated, advanced non-squamous non-small cell lung cancer (NSCLC) lacking targetable genetic aber
Externí odkaz:
https://doaj.org/article/fdb91b26d5c140a091e7bb29d25efe1c
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
The histological transformation from epidermal growth factor receptor (EGFR)-mutated adenocarcinoma (ADC) to squamous cell carcinoma (SCC) after tyrosine kinase inhibitor (TKI) treatment is rare. We present a case of a patient who transitioned from e
Externí odkaz:
https://doaj.org/article/5de6e5f7c1554f829f1bfb601f92c3f8
Autor:
Jiatao Liao, Hongyan Lai, Chang Liu, Xin Zhang, Qiuxiang Ou, Qiaojuan Li, Yan Li, Zhen Wang, Cuicui Liu, Xianghua Wu, Huijie Wang, Hui Yu, Si Sun, Xinmin Zhao, Zhihuang Hu, Yao Zhang, Ying Lin, Bo Yu, Shenglin Huang, Jialei Wang
Publikováno v:
Cancer Science.
Autor:
Hongyan Lai, Yuchen Li, Hena Zhang, Jia Hu, Jiatao Liao, Ying Su, Qin Li, Bing Chen, Caiping Li, Zhen Wang, Yan Li, Jialei Wang, Zhiqiang Meng, Zhaohui Huang, Shenglin Huang
Publikováno v:
Nucleic Acids Research
Extracellular vesicles (EVs) are small membranous vesicles that contain an abundant cargo of different RNA species with specialized functions and clinical implications. Here, we introduce an updated online database (http://www.exoRBase.org), exoRBase
Autor:
Chang Liu, Cuicui Liu, Jiatao Liao, Jiani C. Yin, Xianghua Wu, Xinmin Zhao, Si Sun, Huijie Wang, Zhihuang Hu, Yao Zhang, Hui Yu, Yang Shao, Jialei Wang
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 171
Crizotinib remains one of the most commonly used targeted therapies for ALK fusion-positive patients. However, the mutational profiles and mechanisms of resistance to first-line crizotinib treatment remain to be thoroughly examined.We retrospectively
Autor:
Jiatao Liao, Hongyan Lai, Chang Liu, Yan Li, Xin Chen, Zhen Wang, Cuicui Liu, Qiuxiang Ou, Xianghua Wu, Huijie Wang, Hui Yu, Si Sun, Xinmin Zhao, Zhihuang Hu, Yao Zhang, Ying Lin, Shenglin Huang, Jialei Wang
Publikováno v:
SSRN Electronic Journal.
Autor:
Xinmin Zhao, Chang Liu, Ying Lin, Huijie Wang, Jiatao Liao, Hui Yu, Yao Zhang, Si Sun, Qianqian Long, Jialei Wang, Xianghua Wu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
BackgroundThe addition of bevacizumab or pembrolizumab to pemetrexed-platinum chemotherapy has produced significant clinical benefits to patients with untreated, advanced non-squamous non-small cell lung cancer (NSCLC) lacking targetable genetic aber